253 related articles for article (PubMed ID: 35390309)
21. HNF1β is a sensitive and specific novel marker for yolk sac tumor: a tissue microarray analysis of 601 testicular germ cell tumors.
Gallo A; Fankhauser C; Hermanns T; Beyer J; Christiansen A; Moch H; Bode PK
Mod Pathol; 2020 Nov; 33(11):2354-2360. PubMed ID: 32561848
[TBL] [Abstract][Full Text] [Related]
22. Cytokeratin 7, inhibin, and p63 in testicular germ cell tumor: superior markers of choriocarcinoma compared to β-human chorionic gonadotropin.
Wegman SJ; Parwani AV; Zynger DL
Hum Pathol; 2019 Feb; 84():254-261. PubMed ID: 30359635
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide expression profiling reveals new insights into pathogenesis and progression of testicular germ cell tumors.
Biermann K; Heukamp LC; Steger K; Zhou H; Franke FE; Sonnack V; Brehm R; Berg J; Bastian PJ; Muller SC; Wang-Eckert L; Buettner R
Cancer Genomics Proteomics; 2007; 4(5):359-67. PubMed ID: 17993720
[TBL] [Abstract][Full Text] [Related]
24. The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expression.
Nettersheim D; Gillis A; Biermann K; Looijenga LH; Schorle H
Genes Chromosomes Cancer; 2011 Dec; 50(12):1033-42. PubMed ID: 21987446
[TBL] [Abstract][Full Text] [Related]
25. Topoisomerase II alpha expression in testicular germ cell tumors.
Dimov ND; Zynger DL; Luan C; Kozlowski JM; Yang XJ
Urology; 2007 May; 69(5):955-61. PubMed ID: 17482942
[TBL] [Abstract][Full Text] [Related]
26. CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors.
Fankhauser CD; Roth L; Grossmann NC; Kranzbühler B; Eberli D; Sulser T; Moch H; Bode PK; Beyer J; Hermanns T
BMC Cancer; 2019 Aug; 19(1):802. PubMed ID: 31412792
[TBL] [Abstract][Full Text] [Related]
27. Primary germ cell tumors of the mediastinum: III. Yolk sac tumor, embryonal carcinoma, choriocarcinoma, and combined nonteratomatous germ cell tumors of the mediastinum--a clinicopathologic and immunohistochemical study of 64 cases.
Moran CA; Suster S; Koss MN
Cancer; 1997 Aug; 80(4):699-707. PubMed ID: 9264353
[TBL] [Abstract][Full Text] [Related]
28. CD10 is frequently expressed in classical seminomas.
Del Sordo R; Ascani S; Bellezza G; Ferri I; Sbaraglia M; Sidoni A
Histol Histopathol; 2014 Jan; 29(1):101-6. PubMed ID: 23857215
[TBL] [Abstract][Full Text] [Related]
29. ZBTB16: a novel sensitive and specific biomarker for yolk sac tumor.
Xiao GQ; Li F; Unger PD; Katerji H; Yang Q; McMahon L; Burstein DE
Mod Pathol; 2016 Jun; 29(6):591-8. PubMed ID: 26916077
[TBL] [Abstract][Full Text] [Related]
30. Seminoma component of mixed testicular germ cell tumor shows a higher incidence of loss of heterozygosity than pure-type seminoma.
Miyai K; Ito K; Nakanishi K; Tsuda H
Hum Pathol; 2019 Feb; 84():71-80. PubMed ID: 30266250
[TBL] [Abstract][Full Text] [Related]
31. In Search of TGCT Biomarkers: A Comprehensive
Raos D; Krasic J; Masic S; Abramovic I; Coric M; Kruslin B; Katusic Bojanac A; Bulic-Jakus F; Jezek D; Ulamec M; Sincic N
Dis Markers; 2020; 2020():8841880. PubMed ID: 33224314
[TBL] [Abstract][Full Text] [Related]
32. The utility of CDX2, GATA3, and DOG1 in the diagnosis of testicular neoplasms: an immunohistochemical study of 109 cases.
Osman H; Cheng L; Ulbright TM; Idrees MT
Hum Pathol; 2016 Feb; 48():18-24. PubMed ID: 26772394
[TBL] [Abstract][Full Text] [Related]
33. Oncofetal protein glypican-3 in testicular germ-cell tumor.
Ota S; Hishinuma M; Yamauchi N; Goto A; Morikawa T; Fujimura T; Kitamura T; Kodama T; Aburatani H; Fukayama M
Virchows Arch; 2006 Sep; 449(3):308-14. PubMed ID: 16896894
[TBL] [Abstract][Full Text] [Related]
34. Gene expression microarray analysis of adult testicular germ cell tumor: a comparison between pure-type seminomas and seminoma components in mixed tumors.
Miyai K; Yonekura Y; Ito K; Matsukuma S; Tsuda H
Virchows Arch; 2021 Dec; 479(6):1177-1186. PubMed ID: 34347114
[TBL] [Abstract][Full Text] [Related]
35. Testicular Tumors: A Contemporary Update on Morphologic, Immunohistochemical and Molecular Features.
Al-Obaidy KI; Idrees MT
Adv Anat Pathol; 2021 Jul; 28(4):258-275. PubMed ID: 33871428
[TBL] [Abstract][Full Text] [Related]
36. Spontaneous regression of testicular germ cell tumors: an analysis of 42 cases.
Balzer BL; Ulbright TM
Am J Surg Pathol; 2006 Jul; 30(7):858-65. PubMed ID: 16819328
[TBL] [Abstract][Full Text] [Related]
37. CDX2 expression in yolk sac component of testicular germ cell tumors.
Bing Z; Pasha T; Tomaszewski JE; Zhang P
Int J Surg Pathol; 2009 Oct; 17(5):373-7. PubMed ID: 19578052
[TBL] [Abstract][Full Text] [Related]
38. Fibrillin-1 (FBN-1) a new marker of germ cell neoplasia in situ.
Cierna Z; Mego M; Jurisica I; Machalekova K; Chovanec M; Miskovska V; Svetlovska D; Kalavska K; Rejlekova K; Kajo K; Mardiak J; Babal P
BMC Cancer; 2016 Aug; 16():597. PubMed ID: 27487789
[TBL] [Abstract][Full Text] [Related]
39. Protein overexpression and gene amplification of epidermal growth factor receptor in adult testicular germ cell tumors: potential role in tumor progression.
Miyai K; Yamamoto S; Asano T; Tamai S; Matsubara O; Tsuda H
Cancer Sci; 2010 Sep; 101(9):1970-6. PubMed ID: 20608935
[TBL] [Abstract][Full Text] [Related]
40. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: IV: Current and Future Utilization of Molecular-Genetic Tests for Testicular Germ Cell Tumors.
Looijenga LHJ; Van der Kwast TH; Grignon D; Egevad L; Kristiansen G; Kao CS; Idrees MT
Am J Surg Pathol; 2020 Jul; 44(7):e66-e79. PubMed ID: 32205480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]